QQ客服 官方微博 反馈留言

	OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
	Yuan, Chunling; Guo, Xiaoli; Zhou, Qifan; Du, Fangyu; Jiang, Wei; Zhou, Xiaoyu; Liu, Peng; Chi, Tianyan; Ji, Xuefei; Gao, Jinheng
刊名	BBA - Molecular Basis of Disease
	2019
卷号	Vol.1865 No.1页码:161-180
关键词	ALZHEIMER'S disease *MILD cognitive impairment *SECRETASE inhibitors *AMYLOID beta-protein precursor *SMALL molecules
ISSN号	0925-4439
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4741325
专题	湖南大学
作者单位	Department of Pharmacology, Life Science and Biopharmaceutics School, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning 110016, PR China
推荐引用方式 GB/T 7714	Yuan, Chunling,Guo, Xiaoli,Zhou, Qifan,et al. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.[J]. BBA - Molecular Basis of Disease,2019,Vol.1865 No.1:161-180.
APA	Yuan, Chunling.,Guo, Xiaoli.,Zhou, Qifan.,Du, Fangyu.,Jiang, Wei.,...&Zou, Libo.(2019).OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice..BBA - Molecular Basis of Disease,Vol.1865 No.1,161-180.
MLA	Yuan, Chunling,et al."OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.".BBA - Molecular Basis of Disease Vol.1865 No.1(2019):161-180.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。